Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®
- PMID: 22305839
- PMCID: PMC3273846
- DOI: 10.1016/j.ahj.2011.08.024
Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®
Abstract
Background: There are many factors hypothesized as contributing to overuse of percutaneous coronary intervention (PCI) in the United States, including financial ties between physicians and hospitals, but empirical data are lacking. We examined PCI indications in not-for-profit (NFP), major teaching, for-profit (FP), and physician-owned specialty hospitals.
Methods: A retrospective cohort study of 1,113,554 patients who underwent PCI in 694 hospitals (NFP 471, teaching 131, FP 79, specialty 13) participating in the CathPCI Registry® between January 1, 2004, and December 31, 2007. Percutaneous coronary intervention indications derived from American College of Cardiology Guidelines were classified as survival benefit (patients with primary reperfusion for ST-elevation myocardial infarction), potential quality of life benefit (patients with non-ST-elevation myocardial infarction, acute coronary syndrome (ACS), positive stress test, or chest pain), or unclear indications (patients receiving PCI without an obvious potential survival or quality of life benefit).
Results: The percentage of PCI performed for unclear indications was somewhat higher for specialty hospitals (5.1% of all procedures) as compared with other hospital categories (FP 4.7%, NFP 4.2%, major teaching 4.5%; P < .001). Overall, 17% of hospitals had ≥20% of their total PCI procedures performed for unclear indications, but the proportion of FP, NFP, major teaching, and specialty hospitals reaching this threshold was not statistically different (20%, 16%, 17%, and 15%, respectively; P = .84).
Conclusions: A small proportion of PCI procedures were performed in patients with unclear indications, but there was wide variation across hospitals. On average, specialty hospitals performed more PCIs for unclear indications. Efforts to reduce variability should be pursued.
Copyright © 2012 Mosby, Inc. All rights reserved.
Figures
Similar articles
-
Percutaneous coronary intervention outcomes in US hospitals with varying structural characteristics: analysis of the NCDR®.Am Heart J. 2012 Feb;163(2):222-9.e1. doi: 10.1016/j.ahj.2011.10.010. Am Heart J. 2012. PMID: 22305840 Free PMC article.
-
Appropriateness of percutaneous coronary intervention.JAMA. 2011 Jul 6;306(1):53-61. doi: 10.1001/jama.2011.916. JAMA. 2011. PMID: 21730241 Free PMC article.
-
Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.PLoS One. 2015 Sep 17;10(9):e0138251. doi: 10.1371/journal.pone.0138251. eCollection 2015. PLoS One. 2015. PMID: 26379053 Free PMC article.
-
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR.Circ Cardiovasc Qual Outcomes. 2012 May;5(3):290-7. doi: 10.1161/CIRCOUTCOMES.112.966044. Epub 2012 May 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22576845 Free PMC article.
-
Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.JAMA Cardiol. 2020 Jul 1;5(7):765-772. doi: 10.1001/jamacardio.2020.0753. JAMA Cardiol. 2020. PMID: 32347890 Free PMC article.
Cited by
-
Development of an approach to extracting coronary arteries and detecting stenosis in invasive coronary angiograms.J Med Imaging (Bellingham). 2022 Jul;9(4):044002. doi: 10.1117/1.JMI.9.4.044002. Epub 2022 Jul 19. J Med Imaging (Bellingham). 2022. PMID: 35875389 Free PMC article.
-
Regional variations in the process of care for patients undergoing percutaneous coronary intervention in Japan.Lancet Reg Health West Pac. 2022 Mar 15;22:100425. doi: 10.1016/j.lanwpc.2022.100425. eCollection 2022 May. Lancet Reg Health West Pac. 2022. PMID: 35308578 Free PMC article.
-
Coronary revascularization in patients with stable coronary disease and diabetes mellitus.Diab Vasc Dis Res. 2021 Mar-Apr;18(2):14791641211002469. doi: 10.1177/14791641211002469. Diab Vasc Dis Res. 2021. PMID: 33926268 Free PMC article.
-
Defending waste, fraud, and abuse.Clin Orthop Relat Res. 2014 Aug;472(8):2329-33. doi: 10.1007/s11999-014-3618-6. Epub 2014 Apr 17. Clin Orthop Relat Res. 2014. PMID: 24740317 Free PMC article. No abstract available.
-
A fitting machine learning prediction model for short-term mortality following percutaneous catheterization intervention: a nationwide population-based study.Ann Transl Med. 2019 Dec;7(23):732. doi: 10.21037/atm.2019.12.21. Ann Transl Med. 2019. PMID: 32042748 Free PMC article.
References
-
- Holmes JS, Kozak LJ, Owings MF. Use and in-hospital mortality associated with two cardiac procedures, by sex and age: national trends, 1990-2004. Health Aff (Millwood) 2007 Jan-Feb;26(1):169–177. - PubMed
-
- Groeneveld PW, Matta MA, Greenhut AP, Yang F. The costs of drug-eluting coronary stents among Medicare beneficiaries. American Heart Journal. 2008 Jun;155(6):1097–1105. - PubMed
-
- Kozak LJ, Lees KA, DeFrances CJ. National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data. Vital and Health Statistics. Series 13: Data from the National Health Survey. 2006 May;(160):1–206. - PubMed
-
- Writing Group M. Lloyd-Jones D, Adams R, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 January 27;119(3):480–486. 2009. - PubMed
-
- Klein B, Zahn R, Heer T, et al. [Temporal trends in the use of drug-eluting stents in German clinical practice] Herz. 2008 Sep;33(6):450–454. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous